---
annotations:
- id: PW:0000263
  parent: regulatory pathway
  type: Pathway Ontology
  value: altered regulatory pathway
- id: DOID:162
  parent: disease of cellular proliferation
  type: Disease Ontology
  value: cancer
authors:
- Ruudweijer
- MaintBot
- Khanspers
- Fehrhart
- AlexanderPico
- Eweitz
citedin:
- link: PMC11792194
  title: Enhanced therapeutic effects of hypoxia-preconditioned mesenchymal stromal
    cell-derived extracellular vesicles in renal ischemic injury (2025)
communities: []
description: Photodynamic therapy may induce an antioxidant response mediated by NFE2L2.   Proteins
  on this pathway have targeted assays available via the [CPTAC Assay Portal](https://assays.cancer.gov/available_assays?wp_id=WP3612).
last-edited: 2025-03-08
ndex: 2d52b764-8b67-11eb-9e72-0ac135e8bacf
organisms:
- Homo sapiens
redirect_from:
- /index.php/Pathway:WP3612
- /instance/WP3612
- /instance/WP3612_r137768
revision: r137768
schema-jsonld:
- '@context': https://schema.org/
  '@id': https://wikipathways.github.io/pathways/WP3612.html
  '@type': Dataset
  creator:
    '@type': Organization
    name: WikiPathways
  description: Photodynamic therapy may induce an antioxidant response mediated by
    NFE2L2.   Proteins on this pathway have targeted assays available via the [CPTAC
    Assay Portal](https://assays.cancer.gov/available_assays?wp_id=WP3612).
  keywords:
  - ABCC2
  - ABCC3
  - ABCC4
  - ABCC6
  - ABCG2
  - CES1
  - EPHX1
  - FOS
  - GCLC
  - GCLM
  - GSTP1
  - HMOX1
  - JUN
  - KEAP1
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - NFE2L2
  - NQO1
  - NQO2
  - SRXN1
  license: CC0
  name: Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling
seo: CreativeWork
title: Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling
wpid: WP3612
---